{'52WeekChange': 0.56198347,
 'SandP52WeekChange': None,
 'address1': '149 Commonwealth Drive',
 'address2': 'Suite 2070',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.87,
 'askSize': 3200,
 'averageDailyVolume10Day': 2252825,
 'averageVolume': 3827957,
 'averageVolume10days': 2252825,
 'beta': 1.816806,
 'beta3Year': None,
 'bid': 1.8,
 'bidSize': 21500,
 'bookValue': 0.603,
 'category': None,
 'circulatingSupply': None,
 'city': 'Menlo Park',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.87,
 'dayLow': 1.77,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.153,
 'enterpriseToRevenue': 540.531,
 'enterpriseValue': 245941536,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '650 473 7700',
 'fiftyDayAverage': 1.9394286,
 'fiftyTwoWeekHigh': 2.4,
 'fiftyTwoWeekLow': 0.75,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 183991933,
 'forwardEps': -0.32,
 'forwardPE': -5.7187505,
 'fromCurrency': None,
 'fullTimeEmployees': 45,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.0040700003,
 'heldPercentInstitutions': 0.31497,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1405987200,
 'lastSplitFactor': '1058:1000',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/geron.com',
 'longBusinessSummary': 'Geron Corporation, a late-stage clinical '
                        'biopharmaceutical company, focuses on the development '
                        'and commercialization of therapeutics for hematologic '
                        'myeloid malignancies. It holds rights to imetelstat, '
                        'a telomerase inhibitor in Phase 2/3 clinical trials, '
                        'which inhibits the uncontrolled proliferation of '
                        'malignant progenitor cells in hematologic myeloid '
                        'malignancies to reduce dysfunctional blood cell '
                        'production and enable recovery of normal blood cell '
                        'production. The company was founded in 1990 and is '
                        'headquartered in Menlo Park, California.',
 'longName': 'Geron Corporation',
 'market': 'us_market',
 'marketCap': 567971648,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_215864',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -74844000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.88,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -1.45,
 'phone': '650 473 7700',
 'previousClose': 1.89,
 'priceHint': 4,
 'priceToBook': 3.034826,
 'priceToSalesTrailing12Months': 1248.2893,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.87,
 'regularMarketDayLow': 1.77,
 'regularMarketOpen': 1.88,
 'regularMarketPreviousClose': 1.89,
 'regularMarketPrice': 1.88,
 'regularMarketVolume': 2316759,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 310367008,
 'sharesPercentSharesOut': 0.0864,
 'sharesShort': 26821628,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 17356339,
 'shortName': 'Geron Corporation',
 'shortPercentOfFloat': 0.086899996,
 'shortRatio': 5.73,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'GERN',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.387,
 'twoHundredDayAverage': 1.4465468,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'c31a9eb1-93e6-345d-be75-d9dfbe5121ea',
 'volume': 2316759,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.geron.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94025'}